Precigen
PGEN
#5373
Rank
โ‚น143.93 B
Marketcap
โ‚น403.73
Share price
-0.93%
Change (1 day)
236.08%
Change (1 year)

Revenue for Precigen (PGEN)

Revenue in 2025 (TTM): โ‚น0.85 Billion

According to Precigen's latest financial reports the company's current revenue (TTM ) is โ‚น0.92 Billion. an increase over the revenue in the year 2024 that were of โ‚น0.33 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Precigen from 2012 to 2025

Annual revenue

Year Revenue Change
2025 โ‚น0.86 B158.18%
2024 โ‚น0.33 B-35.03%
2023 โ‚น0.51 B-76.73%
2022 โ‚น2.22 B-46.46%
2021 โ‚น4.15 B-44.88%
2020 โ‚น7.54 B28.92%
2019 โ‚น5.85 B-47.87%
2018 โ‚น11.22 B-23.95%
2017 โ‚น14.76 B13.79%
2016 โ‚น12.97 B12.46%
2015 โ‚น11.53 B153.07%
2014 โ‚น4.55 B214.18%
2013 โ‚น1.45 B90.31%
2012 โ‚น0.76 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Organovo
ONVO
โ‚น13.71 M-98.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
โ‚น2.07 B 125.52%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
โ‚น103.13 B 11,085.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
โ‚น64.21 B 6,864.21% Jersey